ADRO - Aduro Biotech, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - ADRO (1435049)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
60 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
S41-1-2-10-36

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

DM
2017-08-10
ADRODubensky Thomas W.Chief Scientific OfficerS - Sale+OE$11.38-50,00039,900-56%-$569,203
D
2017-08-07
ADROIsaacs Stephen TPres, CEOS - Sale+OE$12.19-40,000174,682-19%-$487,564
DM
2017-08-07
ADROSchafer Gregory WCOOS - Sale+OE$12.17-40,000120,979-25%-$486,783
D
2017-08-07
ADROBrockstedt Dirk G.EVP of Research, Dev.S - Sale+OE$12.18-10,00049,300-17%-$121,795
D
2017-08-07
ADROLew JenniferSVP of FinanceS - Sale+OE$12.17-6,60042,595-13%-$80,290
D
2017-07-03
ADROLew JenniferSVP of FinanceS - Sale+OE$11.14-12,00042,595-22%-$133,632
DM
2017-07-03
ADROIsaacs Stephen TPres, CEOS - Sale+OE$11.06-40,000174,682-19%-$442,397
D
2017-07-03
ADROBrockstedt Dirk G.EVP of Research, Dev.S - Sale+OE$11.02-10,00049,300-17%-$110,167
DM
2017-07-03
ADRODubensky Thomas W.Chief Scientific OfficerS - Sale+OE$11.33-50,00039,900-56%-$566,638
D
2017-06-28
ADROLew JenniferSVP of FinanceS - Sale+OE$11.19-12,00042,595-22%-$134,236
D
2017-06-28
ADROSchafer Gregory WCOOS - Sale+OE$11.26-40,000120,979-25%-$450,568
D
2017-06-19
ADROIsaacs Stephen TPres, CEOS - Sale+OE$10.50-40,000174,682-19%-$420,164
DM
2017-06-01
ADRODubensky Thomas W.Chief Scientific OfficerS - Sale+OE$10.03-144,30139,900-78%-$1,447,777
D
2017-06-01
ADROBrockstedt Dirk G.EVP of Research, Dev.S - Sale+OE$10.00-8,00049,300-14%-$80,020
2017-05-17
ADROBrockstedt Dirk G.EVP of Research, Dev.S - Sale$9.65-1,01149,300-2%-$9,756
2017-05-17
ADROTempleman BlaineEVP, GCS - Sale$9.65-1,64837,300-4%-$15,903
DM
2017-05-15
ADROIsaacs Stephen TPres, CEOS - Sale+OE$10.01-27,273174,682-14%-$272,950
D
2017-05-11
ADROBrockstedt Dirk G.EVP of Research, Dev.S - Sale+OE$9.72-8,00049,300-14%-$77,725
DM
2017-05-11
ADRODubensky Thomas W.Chief Scientific OfficerS - Sale+OE$9.92-5,69939,900-12%-$56,528
D
2017-04-03
ADROBrockstedt Dirk G.EVP of Research, Dev.S - Sale+OE$10.71-8,00049,300-14%-$85,645-3-3+6
D
2017-04-03
ADROIsaacs Stephen TPres, CEOS - Sale+OE$10.28-27,273172,857-14%-$280,429-3-3+6
D
2017-03-13
ADROIsaacs Stephen TPres, CEOS - Sale+OE$11.35-27,273172,857-14%-$309,434+3+5-14
D
2017-03-09
ADROBrockstedt Dirk G.EVP of Research, Dev.S - Sale+OE$11.00-8,00049,300-14%-$88,00100-23
D
2017-03-09
ADRODubensky Thomas W.Chief Scientific OfficerS - Sale+OE$10.96-25,00039,900-39%-$274,07800-23
D
2017-01-17
ADROBrockstedt Dirk G.EVP of Research, Dev.S - Sale+OE$11.86-8,00049,300-14%-$94,858+1+1+4
2017-01-11
ADROTempleman BlaineEVP, GCS - Sale$11.95-3,78537,300-9%-$45,231-4-10-13
D
2017-01-03
ADRODubensky Thomas W.Chief Scientific OfficerS - Sale+OE$11.16-25,00039,900-39%-$278,990-2-10
D
2017-01-03
ADROIsaacs Stephen TPres, CEOS - Sale+OE$11.12-27,273172,857-14%-$303,289-2-10
D
2016-12-01
ADROIsaacs Stephen TPres, CEOS - Sale+OE$10.82-27,273223,857-11%-$295,169+4+2+4
D
2016-12-01
ADRODubensky Thomas W.Chief Scientific OfficerS - Sale+OE$10.94-25,00039,900-39%-$273,500+4+2+4
2016-11-14
ADROHaghighat RossDirS - Sale$15.50-7,08881,880-8%-$109,864+1+1-18
D
2016-11-14
ADROIsaacs Stephen TPres, CEOS - Sale+OE$15.26-27,273223,857-11%-$416,050+1+1-18
D
2016-11-10
ADROLew JenniferSVP of FinanceS - Sale+OE$14.95-10,91042,595-20%-$163,105-6-8-27
DM
2016-11-10
ADROSchafer Gregory WCOOS - Sale+OE$14.78-80,00085,979-48%-$1,182,731-6-8-27
D
2016-11-10
ADRODubensky Thomas W.Chief Scientific OfficerS - Sale+OE$14.78-25,00039,900-39%-$369,408-6-8-27
D
2016-10-03
ADROIsaacs Stephen TPres, CEOS - Sale+OE$12.67-27,273223,857-11%-$345,522-6-6-22-33
D
2016-10-03
ADRODubensky Thomas W.Chief Scientific OfficerS - Sale+OE$12.68-25,00039,900-39%-$316,908-6-6-22-33
D
2016-09-19
ADROLew JenniferSVP of FinanceS - Sale+OE$14.95-6,36042,595-13%-$95,082+1-7-23-28
D
2016-09-01
ADRODubensky Thomas W.Chief Scientific OfficerS - Sale+OE$14.03-25,0000-100%-$350,775+7-4-12-25
D
2016-08-11
ADRODubensky Thomas W.Chief Scientific OfficerS - Sale+OE$15.18-25,0000-100%-$379,500+3-3-9-30
D
2016-07-05
ADRODubensky Thomas W.Chief Scientific OfficerS - Sale+OE$11.61-25,0000-100%-$290,250+20+23-4
2016-05-16
ADROBrockstedt Dirk G.SVP of Research, Dev.S - Sale$8.20-90512,000-7%-$7,421-3+8+16+52
2016-05-16
ADROSchafer Gregory WCOOS - Sale$8.20-90549,279-2%-$7,421-3+8+16+52
2016-05-16
ADRODubensky Thomas W.Chief Scientific OfficerS - Sale$8.20-9050-100%-$7,421-3+8+16+52
D
2016-01-11
ADROBrockstedt Dirk G.SVP of Research, Dev.S - Sale+OE$21.77-22,00012,000-65%-$479,015+2-7-39-40
D
2016-01-08
ADROSchafer Gregory WCOOS - Sale+OE$23.58-20,00049,279-29%-$471,600+2-7-39-40
D
2016-01-04
ADRODubensky Thomas W.Chief Scientific OfficerS - Sale+OE$26.37-15,0000-100%-$395,531-4-8-35-48
DM
2016-01-04
ADROIsaacs Stephen TPres, CEOS - Sale+OE$26.31-25,000166,157-13%-$657,799-4-8-35-48
D
2016-01-06
ADROLew JenniferSVP of FinanceS - Sale+OE$25.71-5,2426,200-46%-$134,765-4-8-35-48
D
2015-12-10
ADROBrockstedt Dirk G.SVP of Research, Dev.S - Sale+OE$29.82-25,0000-100%-$745,4230-6-34-65
D
2015-12-07
ADROSchafer Gregory WCOOS - Sale+OE$29.74-25,00034,279-42%-$743,571+5+1-16-58
D
2015-12-03
ADROLew JenniferSVP of FinanceS - Sale+OE$29.85-5,2422,000-72%-$156,486+5+1-16-58
D
2015-12-01
ADROIsaacs Stephen TPres, CEOS - Sale+OE$29.11-25,000156,157-14%-$727,6640+5-5-59
D
2015-12-01
ADRODubensky Thomas W.Chief Scientific OfficerS - Sale+OE$29.27-30,0000-100%-$878,1040+5-5-59
2015-11-30
ADROGreenman William MarinerDirS - Sale$30.65-3,0000-100%-$91,9500+5-5-59
D
2015-11-18
ADROLew JenniferSVP of FinanceS - Sale+OE$28.52-6,7122,000-77%-$191,426-1-6+10-65
D
2015-11-16
ADROIsaacs Stephen TPres, CEOS - Sale+OE$27.54-25,000156,157-14%-$688,490-1-6+10-65
DM
2015-11-16
ADROBrockstedt Dirk G.SVP of Research, Dev.S - Sale+OE$28.34-26,4700-100%-$750,028-1-6+10-65
DM
2015-11-16
ADROSchafer Gregory WCOOS - Sale+OE$28.15-26,47034,279-44%-$745,241-1-6+10-65
DM
2015-11-16
ADRODubensky Thomas W.Chief Scientific OfficerS - Sale+OE$28.27-31,4700-100%-$889,556-1-6+10-65

Real-time CSV? Options? Alerts? Contact us!
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top